Navigation Links
World Think Tank on Type 1 Diabetes Meets in Miami
Date:11/13/2007

Panel of experts to present latest science and findings via MEDIA

TELECONFERENCE

BETHESDA, Md., Nov. 13 /PRNewswire/ --

WHAT: On World Diabetes Day, November 14, leaders in type 1 diabetes

research will present their findings to the media via

teleconference. These scientists represent two international groups

of type 1 diabetes researchers meeting in Miami during the week of

November 14 to share their latest findings and plan future

research.

WHEN: November 14, 2007, 12:00 - 1:30 p.m. (EST)

Four experts will make 15-minute presentations, followed by a 30-

minute Q&A.

WHY: This media teleconference presents an outstanding opportunity for

you to get an update on exciting type 1 diabetes research and

advances, as you put together stories for your readers during

American Diabetes Month in November.

-- Type 1 diabetes is increasing every year, reaching epidemic

proportions in some countries, with the greatest increase in

children under age 5. In response to this phenomenon, diabetes

researchers across the globe have been working to advance the

study, prevention and treatment of type 1 diabetes. As a result,

the way we detect and treat diabetes is dramatically changing. A

simple blood test can now identify the autoantibodies for type 1

diabetes up to 10 years before diagnosis.

-- If diabetes can be delayed, even for a few years, those at risk may

be able to postpone the difficult challenges of controlling their

glucose levels and the development of serious complications. The

serious complications of diabetes include heart disease, stroke,

blindness, kidney damage and lower-limb amputations.

PANEL TOPICS & PRESENTERS:

Advances in the Prevention and Reversal of Type 1 Diabetes

Jay Skyler, MD, MACP, University of Miami

Chairman of Type 1 Diabetes TrialNet and Professor at the

internationally renowned University of Miami's Diabetes Metabolic

Unit, Dr. Skyler will give an overview of the current advances and

planned research efforts toward finding ways to prevent and reverse

type 1 diabetes.

Nasal Insulin and Prevention of Type 1 Diabetes

Olli Simell, MD, PhD, University of Turku, Finland

Physician, researcher, and instructor of international stature, Dr.

Simmel will provide an overview of a study testing nasal insulin to

prevent type 1 diabetes in children in Finland. Finland has the

highest incidence of type 1 diabetes in the world.

Adult Stem Cells and Reversal of Type 1 Diabetes

Massimo Trucco, MD, University of Pittsburgh

Hillman Professor of Pediatric Immunology and Division Director of

Immunogenetics at Children's Hospital of Pittsburgh, Dr. Trucco

will provide an update on the use of adult stem cells in the

reversal of type 1 diabetes. He will also talk about the critical

immunologic steps that lead to autoimmunity in type 1 diabetes and

the use of this information to prevent and possibly cure type 1

diabetes.

Umbilical Cord Infusion to Reduce Type 1 Severity and Reset

Immunity

Michael Haller, MD, University of Florida College of Medicine,

Gainesville

Dr. Haller, an innovative and proficient researcher of diabetes in

children, will share how cord blood is being tested to treat type 1

diabetes in children newly diagnosed with type 1 diabetes.

Preliminary results show that it appears to reduce disease

severity, possibly re-setting the immune system and slowing the

destruction of their insulin-producing cells.

ABOUT THE MEETINGS

The Type 1 Diabetes TrialNet Study Group

This group of type 1 diabetes experts will meet November 12-14 to discuss current and planned research around type 1 diabetes. Researchers at more than 150 medical centers in the U.S., Canada, Europe and Australia have joined this global network dedicated to study the prevention, early detection and treatment of type 1 diabetes. These centers are offering free screenings for relatives of people with type 1 diabetes, as well as clinical trials in prevention, early detection and early onset. Type 1 Diabetes TrialNet is supported by the National Institutes of Health (NIH), Juvenile Diabetes Research Foundation International, and the American Diabetes Association. To learn more about Type 1 Diabetes TrialNet, visit http://www.DiabetesTrialNet.org

The 9th International Congress of the Immunology of Diabetes Society (IDS) and American Diabetes Association (ADA) Research Symposium

International researchers will meet November 14-18 to discuss the latest science and theories in type 1 diabetes research. IDS is an international collaboration created to advance research in the etiology, pathogenesis, prevention and cure of type 1 diabetes. A key area of focus is clinical trials to alter the type 1 diabetes disease process, eventually leading to prevention of this disease. ADA's mission is to prevent and cure diabetes and to improve the lives of all people affected by diabetes.

TO REGISTER FOR THE MEDIA TELECONFERENCE:

Please contact:

Sarah Bakka

sbakka@mmgct.com

301.348.1685


'/>"/>
SOURCE TrialNet
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program
2. Evotec to Present Details of the Positive Phase II Study in Insomnia With EVT 201 at the Worldsleep07 Congress in Cairns/Australia
3. Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds
4. Safety Profile of TAXUS(R) Liberte(TM) Stent System Highlighted in Worlds Largest Stent Registry
5. CeloNova BioSciences Announces Worlds First Line of Fully Color-Coded Embolic Particles at CIRSE: Embozene(TM) Color-Advanced Microspheres
6. Stereotaxis Niobe System Used to Perform More Than 10,000 Procedures Worldwide
7. NexGenix Pharmaceuticals Enters into Exclusive World-wide License to Develop Novel Hsp90 Inhibitors
8. PATH, World Health Organization, and Partners Introduce Meningitis Vaccine in Burkina Faso
9. Doping technique brings nanomechanical devices into the semiconductor world
10. Advanced Instruments Introduces Worlds Fastest High Throughput Freezing Point Osmometer
11. Celebrities and Notables From the Worlds of Film, Television, Music and Sports Join Lifetime Televisions 13th Annual Multi-Platform Stop Breast Cancer For Life Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... 2016  Sequenom, Inc. (NASDAQ: SQNM ), ... through the development of innovative products and services, announced ... United States denied its petition to review ... Sequenom,s U.S. Patent No. 6,258,540 (",540 Patent") are not ... the Supreme Court,s Mayo Collaborative Services v. Prometheus Laboratories ...
(Date:6/27/2016)... ... June 27, 2016 , ... Newly created 4Sight Medical ... to the healthcare market. The company's primary focus is on new product introductions, ... strategies that are necessary to help companies efficiently bring their products to market. ...
(Date:6/27/2016)... , June 27, 2016   Ginkgo Bioworks ... to industrial engineering, was today awarded as one ... selection of the world,s most innovative companies. Ginkgo ... scale for the real world in the nutrition, ... engineers work directly with customers including Fortune 500 ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and ... and the 6000i models are higher end machines that use the more unconventional z-dimension ... light beam from the bottom of the cuvette holder. , FireflySci has developed ...
Breaking Biology Technology:
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 ... subsidiary of Infosys (NYSE: INFY ), and Samsung ... global partnership that will provide end customers with a ... and payment services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ... for financial services, but it also plays a fundamental part ...
(Date:4/19/2016)... , UAE, April 20, 2016 ... implemented as a compact web-based "all-in-one" system solution for ... biometric fingerprint reader or the door interface with integration ... modern access control systems. The minimal dimensions of the ... readers into the building installations offer considerable freedom of ...
(Date:4/13/2016)... CHICAGO , April 13, 2016  IMPOWER physicians ... are setting a new clinical standard in telehealth ... By leveraging the higi platform, IMPOWER patients can ... weight, pulse and body mass index, and, when they ... quick and convenient visit to a local retail location ...
Breaking Biology News(10 mins):